The Priority Review

Tag

Ocular Redness

1 story

  1. Clinical trials

    Alcon posts results of Phase 3 apraclonidine study for ocular redness

    The study enrolled 159 participants and was completed on November 14, 2024. Results were first posted on ClinicalTrials.gov on November 10, 2026.